NYSE · AGX

Argan, Inc.

$542.52 -$26.40 (-4.64%) 1D Market open

Key Metrics

$7.98B
Market cap
49.45×
P/E · TTM
$1.04B
Revenue · TTM
$161.29M
Net income
EPS · TTM $11.43
Dividend yield 0.3%
Free cash flow $486.89M
Beta · 1Y 1.72
EBITDA · TTM $186.55M
Gross margin 20.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Jun 30 high, the share price fell 32%.

    Peak close $798.55 on Jun 30; trough close $542.52 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -32%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 27
    The stock moved +37.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 27
  • Feb 11
    The stock moved +13.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 11

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$7.98B
Enterprise value
Shares outstanding14.0M
52-wk range$197.00 – $805.75
Avg volume · 20D187.6K
Net cash
Book value / share$33.55
IndustryConstruction - Special Trade Contractors
ExchangeNYSE
About Argan, Inc.
IPO dateAug 18, 1995
Employees1409

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E49.45
P/S7.66
P/FCF16.38
EV/EBITDA
EV/Sales
Graham №$92.89

Profitability

Gross 20.9%
Operating 17.7%
Net 15.5%
FCF 46.7%
ROE / ROIC 39.1% · -292.5%

Financial Health

Current ratio1.53
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$421.42M

Cash Flow · TTM

Operating CF $492.81M
Capex −$5.92M
Free cash flow $486.89M
Buybacks $5.98M
Dividends paid $26.21M
Shareholder yield 0.4%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

8.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$92.89 vs $542.52
Trades 5.8× above classic defensive value — priced for growth
Fundamentals through 2026-04-30 · computed by TickerWolf from SEC filings